80 Acres Farms Announces 2024 Capital Raises and Acquisitions
On Feb. 10, 80 Acres Farms in Hamilton, Ohio, announced its 2024 capital raises totaling $115 million and the acquisition of Plantae Biosciences, an Israeli biotechnology company.
The company’s capital raises in 2024 were supported by a combination of new and existing investors, including General Atlantic, Siemens Financial Services, The Western and Southern Life Insurance Company, Barclays Climate Ventures, Virgo Investment Group, Blue Earth Capital, and other leading Midwestern financial institutions.
The acquisition of Plantae Biosciences brings new plant breeding technology to 80 Acres Farms and its technology-focused subsidiary, Infinite Acres. Since 2020, Plantae has collaborated with the Weizmann Institute of Science, a world-renowned research institution, on projects in accelerated plant breeding, via an exclusive license agreement with the Institute’s commercialization arm, Yeda Research and Development Co. Ltd. The researchers who built Plantae are now operating as Infinite Acres Israel.
2024 was an exciting year for 80 Acres Farms, marked by continued growth. Earlier in the year, the company announced the acquisition of Mother Raw, the dressing supplier for its popular salad kits, and the opening of a first-of-its-kind vertical farming Field Lab in The Hague, with technology partners Siemens, SICK Sensors, Signify, and TTA. While investing in growth, the company has remained focused on execution, resulting in a 60% revenue compound annual growth rate (CAGR) over the last three years.